Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)

  • 834 views
Uploaded on

Renub Research......

Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering

More in: Technology , Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
834
On Slideshare
715
From Embeds
119
Number of Embeds
1

Actions

Shares
Downloads
11
Comments
0
Likes
1

Embeds 119

http://www.scoop.it 119

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Personalized Medicine Diagnostics (Flow Cytometry,Sepsis Immunos, Routine Coagulation, PsychiatricDisorders, Tumor Markers, Molecular Blood Typing andOther Testing) Market & ForecastRenub Researchwww.renub.comPublished: June, 2013Copyright © 2013 Renub Research – All Rights Reserved
  • 2. © Renub Research Page 2 of 18Personalized Medicine - Market OverviewPersonalized Medicine is often defined as “the right treatment for the right person at theright time.” Personalized medicine is becoming the place to be in clinical diagnostics aswell and slowly becoming the reality of future in the diagnostics industryBy Technology Segment - Personalized Medicine diagnostics market is expected to growwith a double digit CAGR for the period of 2013 to 2018. It is expected that personalizedmedicine diagnostics market by technology is going to double by 2018 from its currentmarket size in 2012. In this segment, Point of Care Testing and Molecular Diagnosticssegments control the #1 and #2 positions in 2012.By Diseases Segment - Personalized Medicine diagnostics market is expected to be morethan US$ 30 Billion by 2018. Diabetes management test and Cancer management test arethe leading market in this segment.Renub Research report entitled “Personalized Medicine Diagnostics (Flow Cytometry,Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, MolecularBlood Typing and Other Testing)” report provides a comprehensive analysis of theemerging personalized medicine diagnostic market segments, including their dynamics,size, market share, key investors, clinical trials statement, technological trends, companyanalysis and a realistic future potential for personalized medicine in clinical testing. Thereport also entails major drivers and challenges of personalized medicine diagnosticmarket. This 173 page report contains 94 Figures and 16 Tables studies the PersonalizedMedicine Diagnostics Market. This report contains 12 chapters Chapter 1 is Executive Summary Chapter 2 contains worldwide personalized medicine diagnostic market & forecast(2011 – 2018). The market includes technological & disease-wise personalizedmedicine diagnostics market Chapter 3 contains worldwide personalized medicine diagnostic market sharesegment. Segment include Technology, Disease-Wise
  • 3. © Renub Research Page 3 of 18 Chapter 4 contains segment-wise technological personalized diagnostic market &forecast (2010 - 2018) Chapter 5 contains geographical segment-wise personalized diagnostic market &forecast (2011 - 2018) Chapter 6 contains disease-wise personalized diagnostic market share & forecast(2011 - 2018) Chapter 7 contains disease-wise personalized diagnostic market & forecast (2011 -2018) Chapter 8 and 9 contains clinical trial statement and key investors in PersonalizedDiagnostics Medicine Market Chapter 10 and 11 contains growth Drivers & Challenges for Personalized Medicine Chapter 12 contains company analysis of Personalized MedicineCompanies analyzed in this report are: HistoRx A&G Pharmaceuticals Inc 20/20 GeneSystems Tethys Bioscience Genomas IncData SourcesThis report is built using data and information sourced from proprietary databases, primaryand secondary research and in-house analysis by Renub Research team of industry experts.Primary sources include industry surveys and telephone interviews with industry experts.
  • 4. © Renub Research Page 4 of 18Secondary sources information and data has been collected from various printable andnon-printable sources like search engines, News websites, Government Websites, TradeJournals, White papers, Government Agencies, Magazines, Newspapers, Trade associations,Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
  • 5. © Renub Research Page 5 of 18Table of Contents1. Executive Summary2. Worldwide Personalized Medicine Diagnostic Market & Forecast2.1 By Technology – Worldwide Personalized Medicine Diagnostic Market & Forecast2.2 By Diseases – Worldwide Personalized Medicine Diagnostic Market & Forecast3. Worldwide – Personalized Medicine Diagnostic Market Share Segment3.1 By Technology – Worldwide Personalized Medicine Diagnostic Market Share & Forecast3.2 By Disease – Worldwide Personalized Medicine Diagnostic Market Share & Forecast4. By Technology – Personalized Medicine Diagnostic Market & Forecast4.1 Worldwide – Pharmacogenetics Market & Forecast4.2 Worldwide – Pharmacogenomics Market & Forecast4.3 Worldwide – SNP Genotyping Market & Forecast4.4 Worldwide – Pharmacoproteomics Market & Forecast4.5 Worldwide – Biochips Market & Forecast4.6 Worldwide – Point of Care Test Market & Forecast4.7 Worldwide – Molecular Diagnostics Market & Forecast4.8 Worldwide – Genetic Screening Market & Forecast5. By Geographical Segmentation – Personalized Medicine Diagnostic Market & Forecast5.1 North America – Personalized Medicine Diagnostic Market & Forecast5.2 Western Europe (EU5) – Personalized Medicine Diagnostic Market & Forecast6. By Disease – Personalized Medicine Diagnostic Market Share & Forecast6.1 Worldwide – Cardiovascular Management Test Market Share & Forecast6.2 Worldwide – Diabetes Management Test Market Share & Forecast6.3 Worldwide – Coagulation Test Market Share & Forecast6.4 Worldwide – Cancer Management Test Market Share & Forecast
  • 6. © Renub Research Page 6 of 186.5 Worldwide – Infectious Diseases Test Market Share & Forecast7. By Disease – Personalized Medicine Diagnostic Market & Forecast7.1 Worldwide – Cardiovascular Management Test Market & Forecast7.2 Worldwide – Cardiovascular Management Test Market & Forecast (By Segment)7.2.1 Cardiac Marker Immunoassays Market & Forecast7.2.2 Cardiac Risk Markers Market & Forecast7.2.3 Cardiac Markers Molecular Test Market & Forecast7.3 Worldwide – Diabetes Management Test Market & Forecast7.4 Worldwide – Diabetes Management Test Market & Forecast (By Segment)7.4.1 Blood Glucose Monitoring Market & Forecast7.4.2 Hemoglobin A1C (HbA1c) Test Market & Forecast7.5 Worldwide – Coagulation Test Market & Forecast7.6 Worldwide – Coagulation Test Market & Forecast (By Segment)7.6.1 Routine Coagulation Test Market & Forecast7.6.2 Molecular Coagulation Test Market & Forecast7.7 Worldwide – Cancer Management Test Market & Forecast7.8 Worldwide – Cancer Management Test Market & Forecast (By Segment)7.8.1 Pharmacodiagnostic Histology Test Market & Forecast7.8.2 Flow Cytometry Market & Forecast7.8.3 Tumor Markers Market & Forecast7.8.4 Human Papillomavirus (HPV) Test Market & Forecast7.8.5 Molecular Assays Market & Forecast7.8.6 Circulating Tumor Cells Market & Forecast7.9 Worldwide – Infectious Diseases Test Market & Forecast7.10 Worldwide – Infectious Diseases Test Market (By Segment)
  • 7. © Renub Research Page 7 of 187.10.1 Human Immunodeficiency Virus (HIV) CD4 Count Market & Forecast7.10.2 Human Immunodeficiency Virus (HIV) Viral Load Test Market & Forecast7.10.3 Hepatitis C (HCV) Viral Load Test Market & Forecast7.10.4 Hepatitis B (HBV) Viral Load Test Market & Forecast7.10.5 Hospital Acquired Infections (HAI) Molecular Test Market & Forecast7.10.6 Sepsis Immunos Test Market & Forecast7.10.7 Multi Drug Resistant Tuberculosis (MDR-TB) Test Market & Forecast7.11 Worldwide – Microbiology Identification/ Antibiotic Sensitivity Test (ID/AST) Market &Forecast7.12 Worldwide – Psychiatric Disorders Test Market & Forecast7.13 Worldwide – Transplant Tissue Typing (HLA) Test Market & Forecast7.14 Worldwide – Molecular Blood Typing Market & Forecast8. Personalized Medicine Clinical Trial Statement8.1 Biomarker Research for Personalized Medicine in Blood Cancer Patient8.2 Genetic & Environmental Determinants of Immune Phenotype Variance: Establishing a Pathtowards Personalized Medicine8.3 Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation(WARFARIN)8.4 Genetic Analysis for Personalized Medicine for Morbid Obesity8.5 Pharmacogenomics for Antidepressant Guidance & Education8.6 I-SPY 2 Trial (Investigation of Serial Studies to Predict your Therapeutic Response withImaging & Molecular Analysis)8.7 Genetic Mechanisms in Human Hypertension RAAS Inhibition Study8.8 Open Label Study for the Functional Characterization of Drug Metabolism and Transport8.9 Personalized Therapy in Non-Small Cell Lung Cancer8.10 A Pilot Study of Personalized Medicine for Pediatric Asthma9. Key Investors in Personalized Medicine Market10. Key Drivers (Opportunities) of Growth in Personalized Medicine Diagnostic Market10.1 Government Agencies Shaping Personalized Medicine Diagnostic Market
  • 8. © Renub Research Page 8 of 1810.2 Organizations will Profit Together, Not Alone in the Personalized Medicine10.3 The Blockbuster Model of One Drug Fits all is under Pressure11. Challenges in Personalized Medicine Diagnostic Market11.1 Reimbursement Policy & Regulatory Framework11.2 Regulatory Framework11.3 Payers Worry That Cost of Personalized Medicine Could Be Unsustainable12. Company Analysis12.1 HistoRx12.1.1 Focus/Market Served12.1.2 Outlook/ Strategy for Success12.1.3 Products12.2 A&G Pharmaceutical, Inc12.2.1 Focus/Market Served12.2.2 Outlook/Strategy for Success12.2.3 Products12.3 20/20 GeneSystems12.3.1 Focus/Market Served12.3.2 Outlook/Strategy for Success12.3.3 Products12.4 Tethys Bioscience12.4.1 Focus/Market Served12.4.2 Outlook/Strategy for Success12.4.3 Products12.5 Genomas, Inc.12.5.1 Focus/Market Served12.5.2 Products
  • 9. © Renub Research Page 9 of 18List of FiguresFigure 2-1: Worldwide – By Technology Personalized Medicine Diagnostic Market (Million US$), 2010– 2012Figure 2-2: Worldwide – Forecast for By Technology Personalized Medicine Diagnostic Market (MillionUS$), 2013 – 2018Figure 2-3: Worldwide – By Diseases Personalized Medicine Diagnostic Market (Million US$), 2011 –2012Figure 2-4: Worldwide – Forecast for By Diseases Personalized Medicine Diagnostic Market (MillionUS$), 2013 – 2018Figure 3-1: Worldwide – By Technology Personalized Medicine Diagnostic Market Share (Percent),2010 – 2012Figure 3-2: Worldwide – Forecast for By Technology Personalized Medicine Diagnostic Market Share(Percent), 2013 – 2018Figure 4-1: Worldwide – Pharmacogenetics Market (Million US$), 2010 – 2012Figure 4-2: Worldwide – Forecast for Pharmacogenetics Market (Million US$), 2013 – 2018Figure 4-3: Worldwide – Pharmacogenomics Market (Million US$), 2010 – 2012Figure 4-4: Worldwide – Forecast for Pharmacogenomics Market (Million US$), 2013 – 2018Figure 4-5: Worldwide – SNP Genotyping Market (Million US$), 2010 – 2012Figure 4-6: Worldwide – Forecast for SNP Genotyping Market (Million US$), 2013 – 2018Figure 4-7: Worldwide – Pharmacoproteomics Market (Million US$), 2010 – 2012Figure 4-8: Worldwide – Forecast for Pharmacoproteomics Market (Million US$), 2013 – 2018Figure 4-9: Worldwide – Biochips Market (Million US$), 2010 – 2012Figure 4-10: Worldwide – Forecast for Biochips Market (Million US$), 2013 – 2018Figure 4-11: Worldwide – Point of Care Testing Market (Million US$), 2009 – 2012Figure 4-12: Worldwide – Forecast for Point of Care Testing Market (Million US$), 2013 – 2018Figure 4-13: Worldwide – Molecular Diagnostics Market (Million US$), 2010 – 2012Figure 4-14: Worldwide – Forecast for Molecular Diagnostics Market (Million US$), 2013 – 2018Figure 4-15: Worldwide – Genetic Screening Market (Million US$), 2010 – 2012Figure 4-16: Worldwide – Forecast for Genetic Screening Market (Million US$), 2013 – 2018Figure 5-1: North America – Personalized Medicine Diagnostic Market (Million US$), 2011 – 2012Figure 5-2: North America – Forecast for Personalized Medicine Diagnostic Market (Million US$), 2013– 2018Figure 5-3: Western Europe (EU-5) – Personalized Medicine Diagnostic Market (Million US$), 2011 –2012
  • 10. © Renub Research Page 10 of 18Figure 5-4: Western Europe (EU-5) – Forecast for Personalized Medicine Diagnostic Market (MillionUS$), 2013 – 2018Figure 6-1: Worldwide – Cardiovascular Management Test Market Share (Percent), 2011 – 2012Figure 6-2: Worldwide – Forecast for Cardiovascular Management Test Market Share (Percent), 2013– 2018Figure 6-3: Worldwide – Diabetes Management Test Market Share (Percent), 2011 – 2012Figure 6-4: Worldwide – Forecast for Diabetes Management Test Market Share (Percent), 2013 – 2018Figure 6-5: Worldwide – Coagulation Test Market Share (Percent), 2011 – 2012Figure 6-6: Worldwide – Forecast for Coagulation Test Market Share (Percent), 2013 – 2018Figure 6-7: Worldwide – Cancer Management Test Market Share (Percent), 2011 – 2012Figure 6-8: Worldwide – Forecast for Cancer Management Test Market Share (Percent), 2013 – 2018Figure 6-9: Worldwide – Infectious Diseases Test Market Share (Percent), 2011 – 2012Figure 6-10: Worldwide – Forecast for Infectious Diseases Test Market Share (Percent), 2013 – 2018Figure 7-1: Worldwide – Cardiovascular Management Test Market (Million US$), 2011 – 2012Figure 7-2: Worldwide – Forecast for Cardiovascular Management Test Market (Million US$), 2013 –2018Figure 7-3: Worldwide – Cardiac Marker Immunoassays Market (Million US$), 2011 – 2012Figure 7-4: Worldwide – Forecast for Cardiac Marker Immunoassays Market (Million US$), 2013 –2018Figure 7-5: Worldwide – Cardiac Risk Markers Market (Million US$), 2011 – 2012Figure 7-6: Worldwide – Forecast for Cardiac Risk Markers Market (Million US$), 2013 – 2018Figure 7-7: Worldwide – Cardiac Markers Molecular Test Market (Million US$), 2011 – 2012Figure 7-8: Worldwide – Forecast for Cardiac Markers Molecular Test Market (Million US$), 2013 –2018Figure 7-9: Worldwide – Diabetes Management Test Market (Million US$), 2011 – 2012Figure 7-10: Worldwide – Forecast for Diabetes Management Test Market (Million US$), 2013 – 2018Figure 7-11: Worldwide – Blood Glucose Monitoring Market (Million US$), 2011 – 2012Figure 7-12: Worldwide – Forecast for Blood Glucose Monitoring Market (Million US$), 2013 – 2018Figure 7-13: Worldwide – Hemoglobin A1C (HbA1c) Test Market (Million US$), 2011 – 2012Figure 7-14: Worldwide – Forecast for Hemoglobin A1C (HbA1c) Test Market (Million US$), 2013 –2018Figure 7-15: Worldwide – Coagulation Test Market (Million US$), 2011 – 2012Figure 7-16: Worldwide – Forecast for Coagulation Test Market (Million US$), 2013 – 2018Figure 7-17: Worldwide – Routine Coagulation Test Market (Million US$), 2011 – 2012Figure 7-18: Worldwide – Forecast for Routine Coagulation Test Market (Million US$), 2013 – 2018Figure 7-19: Worldwide – Molecular Coagulation Test Market (Million US$), 2011 – 2012Figure 7-20: Worldwide – Forecast for Molecular Coagulation Test Market (Million US$), 2013 – 2018Figure 7-21: Worldwide – Cancer Management Test Market (Million US$), 2011 – 2012
  • 11. © Renub Research Page 11 of 18Figure 7-22: Worldwide – Forecast for Cancer Management Test Market (Million US$), 2013 – 2018Figure 7-23: Worldwide – Pharmacognostic Histology Test Market (Million US$), 2011 – 2012Figure 7-24: Worldwide – Forecast for Pharmacognostic Histology Test Market (Million US$), 2013 –2018Figure 7-25: Worldwide – Flow Cytometry Market (Million US$), 2011 – 2012Figure 7-26: Worldwide – Forecast for Flow Cytometry Market (Million US$), 2013 – 2018Figure 7-27: Worldwide – Tumor Markers Market (Million US$), 2011 – 2012Figure 7-28: Worldwide – Forecast for Tumor Markers Market (Million US$), 2013 – 2018Figure 7-29: Worldwide – Human Papillomavirus (HPV) Test Market (Million US$), 2011 – 2012Figure 7-30: Worldwide – Forecast for Human Papillomavirus (HPV) Test Market (Million US$), 2013 –2018Figure 7-31: Worldwide – Molecular Assays Market (Million US$), 2011 – 2012Figure 7-32: Worldwide – Forecast for Molecular Assays Market (Million US$), 2013 – 2018Figure 7-33: Worldwide – Circulating Tumor Cells Market (Million US$), 2011 – 2012Figure 7-34: Worldwide – Forecast for Circulating Tumor Cells Market (Million US$), 2013 – 2018Figure 7-35: Worldwide – Infectious Diseases Test Market (Million US$), 2011 – 2012Figure 7-36: Worldwide – Forecast for Infectious Diseases Test Market (Million US$), 2013 – 2018Figure 7-37: Worldwide – HIV CD4 Count Market (Million US$), 2011 – 2012Figure 7-38: Worldwide – Forecast for HIV CD4 Count Market (Million US$), 2013 – 2018Figure 7-39: Worldwide – HIV Viral Load Test Market (Million US$), 2011 – 2012Figure 7-40: Worldwide – Forecast for HIV Viral Load Test Market (Million US$), 2013 – 2018Figure 7-41: Worldwide – HCV Viral Load Test Market (Million US$), 2011 – 2012Figure 7-42: Worldwide – Forecast for HCV Viral Load Test Market (Million US$), 2013 – 2018Figure 7-43: Worldwide – HBV Viral Load Test Market (Million US$), 2011 – 2012Figure 7-44: Worldwide – Forecast for HBV Viral Load Test Market (Million US$), 2013 – 2018Figure 7-45: Worldwide – HAI Molecular Test Market (Million US$), 2011 – 2012Figure 7-46: Worldwide – Forecast for HAI Molecular Test Market (Million US$), 2013 – 2018Figure 7-47: Worldwide – Sepsis Immunos Test Market (Million US$), 2011 – 2012Figure 7-48: Worldwide – Forecast for Sepsis Immunos Test Market (Million US$), 2013 – 2018Figure 7-49: Worldwide – Multi Drug Resistant Tuberculosis (MDR-TB) Market (Million US$), 2011 –2012Figure 7-50: Worldwide – Forecast for Multi Drug Resistant Tuberculosis (MDR-TB) Market (MillionUS$), 2013 – 2018Figure 7-51: Worldwide – Microbiology ID/AST Market (Million US$), 2011 – 2012Figure 7-52: Worldwide – Forecast for Microbiology ID/AST Market (Million US$), 2013 – 2018Figure 7-53: Worldwide – Psychiatric Disorders Test Market (Million US$), 2011 – 2012Figure 7-54: Worldwide – Forecast for Psychiatric Disorders Test Market (Million US$), 2013 – 2018Figure 7-55: Worldwide – Transplant Tissue Typing (HLA) Test Market (Million US$), 2011 – 2012Figure 7-56: Worldwide – Forecast for Transplant Tissue Typing (HLA) Test Market (Million US$), 2013– 2018
  • 12. © Renub Research Page 12 of 18Figure 7-57: Worldwide – Molecular Blood Typing Market (Million US$), 2011 – 2012Figure 7-58: Worldwide – Forecast for Molecular Blood Typing Market (Million US$), 2013 – 2018
  • 13. © Renub Research Page 13 of 18List of TablesTable 3-1: Worldwide – By Diseases Personalized Medicine Diagnostic Market Share (Percent), 2011 –2012Table 3-2: Worldwide – Forecast for By Diseases Personalized Medicine Diagnostic Market Share(Percent), 2013 – 2018Table 7-1: Selected Human Papillomavirus (HPV) Tests, 2011Table 7-2: Selected Molecular Personalized Medicine Tests in Cancer, 2011Table 8-1: Clinical Trial – Biomarker Research for Personalized Medicine in Blood Cancer PatientTable 8-2: Clinical Trial – Genetic & Environmental Determinants of Immune Phenotype Variance:Establishing a Path Towards Personalized MedicineTable 8-3: Clinical Trial – Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing atTherapy InitiationTable 8-4: Clinical Trial – Genetic Analysis for Personalized Medicine for Morbid ObesityTable 8-5: Clinical Trial – Pharmacogenomics for Antidepressant Guidance & EducationTable 8-6: Clinical Trial – I-SPY 2 Trial (Investigation of Serial Studies to Predict Your TherapeuticResponse with Imaging & molecular Analysis)Table 8-7: Clinical Trial – Genetic Mechanisms in Human Hypertension RAAS Inhibition StudyTable 8-8: Clinical Trial – Open Label Study for the Functional Characterization of Drug Metabolismand TransportTable 8-9: Clinical Trial – Personalized Therapy in Non-small Cell Lung CancerTable 8-10: Clinical Trial – A Pilot Study of Personalized Medicine for Pediatric AsthmaTable 9-1: Key Investors in Personalized Medicine, 2011 & 2012Table 12-1: Partnership & Alliance Models in Personalized Medicine
  • 14. © Renub Research Page 14 of 18Related ReportsMolecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies& Clinical Trials) to 2017: Global AnalysisPoint of Care Testing Market and Forecast to 2016: Global AnalysisPediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide AnalysisWestern Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)Asia Medical Tourism Analysis and Forecast to 2015Clinical Chemistry Market Report & Forecast (2012 – 2015): Global AnalysisHepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016Influenza Vaccine Market Opportunities and Challenges: Worldwide ForecastGenetic Testing Market and Forecast - Global Analysis 2010 – 2015USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)Global Osteoporosis Market & Drugs Analysis 2010 – 2015Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)Global Molecular Diagnostics Market & Future Forecast 2010 - 2014Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & DrugsAnalysisGlobal Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 – 2014)
  • 15. © Renub Research Page 15 of 18Our Partial List of ClientsBainWAKE Technology Services, Inc.PSS World MedicalRelypsaC&K componentsKonkuk UniversityResoneticsSamsungSEKISUI MEDICAL CO. LTD.Plentyoffish Media INCArthur D Little GmbhMorgan StanleyTakeda Pharmaceutical CorporationHokkai School of CommerceMinistry of Manpower SingaporeGenOmind, LLC.Goldman Sachs & CoNTT Advanced TechnologyTokyo Womens Medical UniversityThe Chemo-Sero-Therapeutic ResearchTrade Council of IcelandJpmorgan, Ets TradingGE Healthcare ITixia communicationsRedbusBecton DickinsonPfizerIntercellSanofi PasteurStanford BurgessPequot CapitalDMITransgene S.A.ixia communicationsToyota Tsusho Amercia Inc.National Health Research InstitutesAbbott Diabetes CareCorning Incorporated - Life SciencesL.E.K. Consulting GmbHSyntironMediVas LLCCredit SuisseDune MedicalQIAGENInje UniversityMapp BiopharmaceuticalInstitute for Information IndustryNorDiag ASARep e Inv Medicas SA deInnogenetics
  • 16. © Renub Research Page 16 of 18Order FormScan and e-mail this page to info@renub.com, alternatively one can also write the ContactInformation in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail toinfo@renub.comFormatReport Title: Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, RoutineCoagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and OtherTesting)Single User(Email from Publisher)Hard Copy(Mail Delivery)CD – Rom(Mail Delivery)Global Site License(Multiple User License)US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200For ordering this report: Three easy ways to place your order:1) Order online by Credit Card (Visa, MasterCard, etc.):http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-1162) Order by Wire Transfer:http://www.renub.com/report/wiretransfer.aspx?id=116&pid=1449To pay by Wire Transfer, please, fill in your contact details in the form below:
  • 17. © Renub Research Page 17 of 18Bank DetailsAccount Name: Renub ResearchA/C No.: 109102000023296Name of Bank: IDBI Bank Ltd.Swift Code: IBKLINBB010Bank Address: 4thFloorIndian Red Cross Building1 Red Cross RoadOpposite Parliament StreetNew Delhi – 110001IndiaContact InformationFirst Name: Last Name:Email:Job Title:Company:Address:City:Postal/Zip Code:Country:Phone:Mobile:Fax:Report Format:Your message:
  • 18. © Renub Research Page 18 of 183) Order by CheckPlease post the check accompanied by this form, to:Company Address: Renub Research1StFloorC-86, Sector -10Noida - 201301Uttar PradeshIndiaPhone: +91-120-421-9822, 424-9780For free Sample copy report or to view any of our sample work please contact us atinfo@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)Follow UsFacebook: http://www.facebook.com/pages/Renub-Research/233380966701090LinkedIn: http://www.linkedin.com/company/renub-researchTwitter: http://twitter.com/RenubResearch